RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model

Journal of Zhejiang University: Science B

Volumn 10, Issue 1, 2009, Pages 22-28

  Chen, Shao Xing ^a   Huang, Feng Ying ^a   Tan, Guang Hong ^a   Wang, Cai Chun ^a   Huang, Yong Hao ^a   Wang, Hua ^a   Zhou, Song Lin ^a   Chen, Fan ^a   Lin, Ying Ying ^a   Liu, Jun Bao ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Airway hyperresponsiveness (AHR); Allergy; Interleukin 5 (IL 5); Lentivirus; Small interfering RNA (siRNA)

Indexed keywords

INTERLEUKIN 5; LENTIVIRUS VECTOR; MESSENGER RNA; SMALL INTERFERING RNA; SODIUM CHLORIDE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHIL COUNT; GENE EXPRESSION; GENE SILENCING; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIBOZYME THERAPY; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA; RNA; TREATMENT OUTCOME;

LENTIVIRUS; MURINAE; MUS;

EID: 58549118978     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0820226     Document Type: Article

References (34)

1. Barthel, S.R., Johansson, M.W., McNamee, D.M., Deane, F., Mosher, D.F., 2008. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J. Leukoc. Biol., 83 (1):1-12. [doi:10.1189/jlb.0607344]
2. Bentley, A.M., Menz, G., Storz, C., Robinson, D.S., Bradley, B., Jeffery, P.K., Durham, S.R., Kay, A.B., 1992. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am. Rev. Respir. Dis., 146 (2):500-506.
3. Blyth, D.I., Wharton, T.F., Pedrick, M.S., Tony, J., Savage, T.J., Sanjar, S., 2000. Airway subepithelial fibrosis in a murine model of atopic asthma. Suppression by dexamethasone or anti-interleukin-5 antibody. Am. J. Respir. Cell Mol. Biol., 23 (2):241-246.
4. Busse, W.W., Lemanske, R.F., 2001. Asthma. N. Engl. J. Med., 344 (5):350-362. [doi:10.1056/NEJM200102013440507]
5. Cho, J.Y., Miller, M., Baek, K.J., Han, J.W., Nayar, J., Lee, S.Y., McElwain, K., McElwain, S., Friedman, S., Broide, D.H., 2004. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest., 113 (4):551-560. [doi:10.1172/JCI19133]
6. Clutterbuck, E.J., Hirst, E.M., Sanderson, C.J., 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood, 73 (6):1504-1512.
7. Durham, S.R., Loegering, D.A., Dunnette, S., Gleich, G.J., Kay, A.B., 1989. Blood eosinophils and eosinophilderived proteins in allergic asthma. J. Allergy Clin. Immunol., 84 (6):931-936. [doi:10.1016/ 0091-6749(89)90391-6]
8. Fixman, E.D., Stewart, A., Martin, J.G., 2007. Basic mechanisms of development of airway structural changes in asthma. Eur. Respir. J., 29 (2):379-389. [doi:10.1183/09031936.00053506]
9. Garlisi, C.G., Kung, T.T., Wang, P., Minnicozzi, M., Umland, S.P., Chapman, R.W., Stelts, D., Crawley, Y., Falcone, A., Myers, J.G., et al., 1999. Effects of chronic antiinterleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am. J. Respir. Cell Mol. Biol., 20 (2):248-255.
10. Gleich, G.J., 1990. The eosinophil and bronchial asthma: Current understanding. J. Allergy Clin. Immunol., 85 (2):422-436. [doi:10.1016/ 0091-6749(90)90151-S]
11. Hakonarson, H., Maskeri, N., Carter, C., Chuang, S., Grunstein, M.M., 1999a. Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest., 104 (5):657-667. [doi:10.1172/JCI7137]
12. Hakonarson, H., Maskeri, N., Carter, C., Grunstein, M.M., 1999b. Regulation of Th1- and Th2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest., 103 (7):1077-1087. [doi:10.1172/JCI5809]
13. Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G.L., Irvin, C.G., Gelfand, E.W., 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med., 156 (3):766-775.
14. Hertz, M., Mahalingam, S., Dalum, I., Klysner, S., Mattes, J., Neisig, A., Mouritsen, S., Foster, P.S., Gautam, A., 2001. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J. Immunol., 167 (7):3792-3799.
15. Humbert, M., 1996. Pro-eosinophilic cytokines in asthma. Clin. Exp. Allergy, 26 (2):123-127. [doi:10.1111/j.1365-2222.1996.tb00069.x]
16. Humbles, A.A., Lloyd, C.M., McMillan, S.J., Friend, D.S., Xanthou, G., McKenna, E.E., Ghiran S., Gerard, N.P., Yu, C., Stuart, H., et al., 2004. A critical role for eosinophils in allergic airways remodeling. Science, 305 (5691):1776-1779. [doi:10.1126/science.1100283]
17. Jiang, Y.F., Zhao, F.D., Li, X.B., Ning, Y.X., Zhi, X.L., Qian, R.Z., Yin, L.H., 2008. Effects of RNA interferenceinduced tryptase down-regulation in P815 cells on IL-6 and TNF-α release of endothelial cells. J. Zhejiang Univ. Sci. B, 9 (8):656-661. [doi:10.1631/ jzus.B0810188]
18. Karras, J.G., McGraw, K., McKay, R.A., Cooper, S.R., Lerner, D., Lu, T., Walker, C., Dean, N.M., Monia, B.P., 2000. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J. Immunol., 164 (10):5409-5415.
19. Kroegel, C., Virchow, J.C., Luttmann, W., Walker, C., Warner, J.A., 1994. Pulmonary immune cells in health and disease: The eosinophil leucocyte. Part I. Eur. Respir. J., 7 (3):519-543. [doi:10.1183/ 09031936.94.07030519]
20. Leckie, M.J., Brinke, A., Khan, J., Diamant, Z., O'Connor, B.J., Walls, C.M., Mathur, A.K., Cowley, H.C., Chung, K.F., Djukanovic, R., et al., 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet, 356 (9248):2144-2148. [doi:10.1016/ S0140-6736(00)03496-6]
21. Mattes, J., Foster, P.S., 2003. Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr. Drug Targets Inflamm. Allergy, 2 (2):169-174. [doi:10.2174/1568010033484214]
22. Menzies-Gow, A., Flood-Page, P., Sehmi, R., Burman, J., Hamid, Q., Robinson, D.S., Kay, A.B., Denburg, J., 2003. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J. Allergy Clin. Immunol., 111 (4):714-719. [doi:10.1067/mai.2003.1382]
23. Popescu, F.D., 2005. Antisense- and RNA interference-based therapeutic strategies in allergy. J. Cell. Mol. Med., 9 (4):840-853. [doi:10.1111/ j.1582-4934.2005.tb00383.x]
24. Robinson, D., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A.M., Corrigan, C., Durham, S.R., Kay, A.B., 1992. Predominant Th2-like bronchoalveolar Tlymphocyte population in atopic asthma. N. Engl. J. Med., 326 (5):298-304.
25. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol., 92 (2):313-324. [doi:10.1016/ 0091-6749(93)90175-F]
26. Sanderson, C.J., 1992. Interleukin-5, eosinophils, and disease. Blood, 79 (12):3101-3109.
27. Shen, H.H., Ochkur, S.I., McGarry, M.P., Crosby, J.R., Hines, E.M., Borchers, M.T., Wang, H., Biechelle, T.L., O'Neill, K.R., Ansay, T.L., et al., 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol., 170 (6):3296-3305.
28. Simon, D., Braathen, L.R., Simon, H.U., 2005. Anti-interleukin-5 antibody therapy in eosinophilic diseases. Pathobiology, 72 (6):287-292. [doi:10.1159/000091326]
29. Sugita, M., Kuribayashi, K., Nakagomi, T., Miyata, S., Matsuyama, T., Kitada, O., 2003. Allergic bronchial asthma: Airway inflammation and hyperresponsiveness. Intern. Med., 42 (8):636-643. [doi:10.2169/ internalmedicine.42.636]
30. Sutton, S.A., Assa'ad, A.H., Rothenberg, M.E., 2005. Anti-IL-5 and hypereosinophilic syndromes. Clin. Immunol., 115 (1):51-60. [doi:10.1016/ j.clim.2005.02.006]
31. Tan, G.H., Su, J.M., Wang, C.C., Huang, F.Y., Wang, H., Huang, Y.H., Lin, Y.Y., 2008. A recombinant DNA plasmid encoding the human interleukin-5 breaks immunological tolerance and inhibits airway inflammation in a murine model of asthma. Int. Arch. Allergy Immunol., 145 (4):313-323. [doi:10.1159/000110890]
32. Tournoy, K.G., Kips, J.C., Pauwels, R.A., 2001. The allergeninduced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent. J. Immunol., 166 (11):6982-6991.
33. Walter, M.J., Holtzman, M.J., 2005. A centennial history of research on asthma pathogenesis. Am. J. Respir. Cell Mol. Biol., 32 (6):483-489. [doi:10.1165/rcmb.F300]
34. Woodruff, P.G., Khashayar, R., Lazarus, S.C., Janson, S., Avila, P., Boushey, H.A., Segal, M., Fahy, J.V., 2001. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J. Allergy Clin. Immunol., 108 (5):753-758. [doi:10.1067/mai.2001.119411]